Compounds > yttrium
Page last updated: 2024-08-22

yttrium and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

yttrium has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chelli, M; Chinol, M; De Luca, A; Ginanneschi, M; Leone, G; Paganelli, G; Papi, S; Papini, AM; Sabatino, G1
Aime, S; Botta, M; Hermann, P; Koridze, A; Rudovský, J1
Czernin, J; Hildebrandt, IJ; McCoy, MR; Meares, C; Olafsen, T; Phelps, ME; Radu, C; Weber, WA; Wei, LH; Wu, AM1
Engelbogen, N; Havlíčková, J; Herdtweck, E; Hermann, P; Kapp, TG; Kessler, H; Notni, J; Šimeček, J; Wester, HJ1
Bendall, SC; Fantl, WJ; Han, G; Nolan, GP; Spitzer, MH1

Other Studies

5 other study(ies) available for yttrium and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

ArticleYear
A new biotin derivative-DOTA conjugate as a candidate for pretargeted diagnosis and therapy of tumors.
    Journal of medicinal chemistry, 2003, Jul-03, Volume: 46, Issue:14

    Topics: Antineoplastic Agents; Avidin; Biotin; Chelating Agents; Drug Stability; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Neoplasms; Protein Binding; Radiopharmaceuticals; Yttrium

2003
Relaxometric and solution NMR structural studies on ditopic lanthanide(III) complexes of a phosphinate analogue of DOTA with a fast rate of water exchange.
    Dalton transactions (Cambridge, England : 2003), 2006, May-21, Issue:19

    Topics: Benzene Derivatives; Chelating Agents; Dysprosium; Europium; Gadolinium; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Organometallic Compounds; Phosphinic Acids; Yttrium

2006
Engineered antibody fragments with infinite affinity as reporter genes for PET imaging.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:11

    Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Base Sequence; Cell Line, Tumor; Feasibility Studies; Gene Expression Regulation, Neoplastic; Genes, Reporter; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin Fragments; Mice; Neoplasms; Positron-Emission Tomography; Protein Engineering; Substrate Specificity; Tissue Distribution; Yttrium

2008
A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2013, Jun-10, Volume: 19, Issue:24

    Topics: Chelating Agents; Copper; Cyclams; Gadolinium; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Integrin alphaVbeta3; Ligands; Lutetium; Molecular Structure; Peptides; Peptides, Cyclic; Phosphinic Acids; Polyethylene Glycols; Radiopharmaceuticals; Thermodynamics; Yttrium

2013
Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry.
    Nature protocols, 2018, Volume: 13, Issue:10

    Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Bismuth; Chelating Agents; Flow Cytometry; Heterocyclic Compounds, 1-Ring; Humans; Immunoassay; Immunoconjugates; Immunoglobulin G; Indium; Isotopes; Jurkat Cells; Metals; Mice, Inbred C57BL; Palladium; Yttrium

2018